These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6478741)

  • 1. Influence of cimetidine on verapamil kinetics and dynamics.
    Smith MS; Benyunes MC; Bjornsson TD; Shand DG; Pritchett EL
    Clin Pharmacol Ther; 1984 Oct; 36(4):551-4. PubMed ID: 6478741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of interaction between verapamil and cimetidine.
    Abernethy DR; Schwartz JB; Todd EL
    Clin Pharmacol Ther; 1985 Sep; 38(3):342-9. PubMed ID: 4028631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing.
    Johnson LM; Lankford SM; Bai SA
    J Vet Pharmacol Ther; 1995 Apr; 18(2):117-23. PubMed ID: 7629925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug action.
    Mikus G; Eichelbaum M; Fischer C; Gumulka S; Klotz U; Kroemer HK
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1042-8. PubMed ID: 2359015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine on verapamil disposition.
    Loi CM; Rollins DE; Dukes GE; Peat MA
    Clin Pharmacol Ther; 1985 Jun; 37(6):654-7. PubMed ID: 4006365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil disposition--effects of sulphinpyrazone and cimetidine.
    Wing LM; Miners JO; Lillywhite KJ
    Br J Clin Pharmacol; 1985 Mar; 19(3):385-91. PubMed ID: 3986090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined alpha adrenoceptor antagonism and calcium channel blockade in normal subjects.
    Pasanisi F; Elliott HL; Meredith PA; McSharry DR; Reid JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):716-23. PubMed ID: 6499353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects.
    Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT
    Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cimetidine and ranitidine on the conversion of prednisone to prednisolone.
    Sirgo MA; Rocci ML; Ferguson RK; Eshelman FN; Vlasses PH
    Clin Pharmacol Ther; 1985 May; 37(5):534-8. PubMed ID: 3987177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of dilevalol.
    Tenero DM; Bottorff MB; Given BD; Kramer WG; Affrime MB; Patrick JE; Lalonde RL
    Clin Pharmacol Ther; 1989 Dec; 46(6):648-56. PubMed ID: 2598569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cimetidine pharmacokinetics].
    Katrukha SP; Karpenko EV; Davydov SM; Blinkov IL; Kukes VG
    Farmakol Toksikol; 1986; 49(5):36-40. PubMed ID: 3770173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma verapamil levels and exercise performance.
    Weiner DA; McCabe CH; Cutler SS; Ryan TJ; Klein MD
    Clin Pharmacol Ther; 1984 Jul; 36(1):25-32. PubMed ID: 6734046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of antituberculosis drugs on the plasma level of verapamil.
    Mooy J; Böhm R; van Baak M; van Kemenade J; vd Vet A; Rahn KH
    Eur J Clin Pharmacol; 1987; 32(1):107-9. PubMed ID: 3582463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the pharmacokinetics and electrocardiographic effects of intravenous verapamil with intravenous calcium chloride pretreatment in normal subjects.
    Schoen MD; Parker RB; Hoon TJ; Hariman RJ; Bauman JL; Beckman KJ
    Am J Cardiol; 1991 Feb; 67(4):300-4. PubMed ID: 1990794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.
    Carosella L; Menichelli P; Alimenti M; Zuccala G; Gemma A; Cocchi A; Carbonin PU
    Cardiovasc Drugs Ther; 1989 Jun; 3(3):417-25. PubMed ID: 2487538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Near-total reduction in verapamil bioavailability by rifampin. Electrocardiographic correlates.
    Barbarash RA; Bauman JL; Fischer JH; Kondos GT; Batenhorst RL
    Chest; 1988 Nov; 94(5):954-9. PubMed ID: 3180898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoking and theophylline metabolism: effects of cimetidine.
    Cusack BJ; Dawson GW; Mercer GD; Vestal RE
    Clin Pharmacol Ther; 1985 Mar; 37(3):330-6. PubMed ID: 3971657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of histamine-2 receptor blockade on lidocaine kinetics.
    Jackson JE; Bentley JB; Glass SJ; Fukui T; Gandolfi AJ; Plachetka JR
    Clin Pharmacol Ther; 1985 May; 37(5):544-8. PubMed ID: 3987178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.